SeptRx
United states-based medical device company developing minimally invasive treatments for structural heart defects.
| Date | Investors | Amount | Round |
|---|---|---|---|
$2.7m | Series A | ||
| Total Funding | 000k | ||
Related Content
SeptRx Inc. is a medical technology company focused on addressing the challenges of sepsis, a life-threatening condition. The company was co-founded by Ashod Mooradian, who serves as President & CEO, and Gevork Mooradian, who is the Chief Technology Officer. Their foundation for this venture stems from personal experience, having lost their father to septic shock, which catalyzed their mission to develop a more effective treatment.
Ashod Mooradian brings over two decades of experience in the medical device industry, with a background that includes significant roles at major corporations like Johnson & Johnson and Medtronic. His career has centered on the development and commercialization of new medical technologies. Gevork Mooradian complements this with his expertise as an engineer, holding over 15 years of experience in product development and obtaining multiple patents in the medical device field.
The company is developing an extracorporeal blood cleansing device designed for the early treatment of sepsis. This technology utilizes proprietary, engineered carbon beads to remove sepsis-causing pathogens and endotoxins directly from the patient's bloodstream. The core of the product is a disposable cartridge containing these specialized carbon beads, which is intended to be compatible with standard hemodialysis equipment already present in most hospitals. This approach aims to provide a cost-effective and easily integrated solution for healthcare providers.
SeptRx's business model centers on the development and future sale of this single-use therapeutic device. The target market includes hospitals and intensive care units that treat patients with sepsis. The primary benefit of the device is its potential to rapidly reduce the pathogen load in the bloodstream, which could prevent the progression to severe sepsis and septic shock, thereby improving patient outcomes and reducing the high costs associated with sepsis treatment.
Keywords: sepsis treatment, septic shock, medical device, blood purification, extracorporeal therapy, hemoadsorption, carbon beads, endotoxin removal, pathogen removal, critical care, intensive care unit, medical technology, hemodialysis, blood cleansing, anti-sepsis device, Ashod Mooradian, Gevork Mooradian, healthcare innovation, therapeutic device, acute care